Meet our speaker - Magdalena Jander
Technology Scout, Biotechnologist, now Chief Executive Officer at GeneaMed LLC – the University Spin-off company, which is developing new class of therapeutics for personalized treatment of blood cancer diseases. Always interested in innovations and new technologies, which might have an impact on the society's health. Her adventure with the commercialization of research results started already during her studies. Magdalena was a laureate of two international fellowships – first at Université Pierre et Marie Curie in Paris and second at Osaka University in Japan. She was carrying out research projects connected with medical applications in biotech and pharma industry. Magdalena completed postgraduate studies in "Market potential assessment of research projects” and specialist course for “The European Technology Transfer Manager”. She holds PhD degree in "Medical Science" from Medical University of Lublin. Presently she is developing a non-profit action about raising awareness for cancer prevention in Poland.
In Impact’18 Agenda
Day I 13.06.2018 Wednesday 13:05 – 13:25
Track: biotechnology & digital health
“Building Bridges: Global BioTech Partnership – Pathway to Success”